TechnoVax, Inc. logo — company profile

TechnoVax, Inc.

Founded 2003 United States United States 5 employees Equity Crowdfunding Health Care

General Information

Company Name TechnoVax, Inc.
Founded Year 2003
Location United States United States +1
Employees 5
Industries Health Care
Funding Stage Equity Crowdfunding
Social

Get notified when TechnoVax, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About TechnoVax, Inc.

TechnoVax, Inc. is a Tarrytown, NY-based biotechnology company founded in 2003. Specializing in viral vaccine development, the company's mission is to create and advance safe, unique, and novel vaccine technologies with no current alternatives, revolutionizing the way vaccines are developed and administered. Their next-generation technology-platform based on Virus-Like Particles (VLP) enhances the development and production of a wide range of vaccines targeting respiratory diseases, hemorrhagic fevers, immunodeficiency, and cancers. With over $5.0 million in non-dilutive funding, TechnoVax is rapidly approaching clinical phases with three main candidates: a Universal flu vaccine, an Inhaled Powder flu vaccine, and an RSV vaccine. The company is actively pursuing strategic partnerships and seeking funding to start human testing, following their last investment in Equity Crowdfunding on 26 September 2013. Their innovative approach and potential for addressing critical global health challenges make them an intriguing prospect for investors in the health care industry.

Taxonomy: vaccine development, Virus-Like Particles, respiratory diseases, hemorrhagic fevers, immunodeficiency, cancer vaccines, Universal flu vaccine, Inhaled Powder flu vaccine, RSV vaccine, strategic partnerships, funding, clinical-stage biotechnology, Tarrytown, NY, non-dilutive funding

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Equity Crowdfunding •••••• - 26 Sep 2013

TechnoVax, Inc. Alternatives & Competitors

TechnoVax, Inc. vs

Changing the World with Silkworms

Series B
10 employees
Biotechnology, Pharmaceutical
TechnoVax, Inc. vs

Developing therapeutic cancer vaccines using ROP technology

Series A
8 employees
Health Care, Health and Wellness
TechnoVax, Inc. vs
CaroGen Corporation
CaroGen Corporation United States

CaroGen Corporation is an emerging biopharmaceutical company with an entirely new vaccine platform t...

Grant
12 employees
Biopharma, Biotechnology

FAQ About TechnoVax, Inc.

TechnoVax is a privately held near-clinical-stage biotechnology company based in Tarrytown, NY specializing in viral vaccine development. Our mission is to create and advance towards the market safe, unique and novel vaccine technologies with no current alternatives that will revolutionize the way v...
TechnoVax, Inc. was founded in 2003.
TechnoVax, Inc. is headquartered in United States.
TechnoVax, Inc. operates in the following industries: Health Care.
TechnoVax, Inc. has approximately 5 employees.
TechnoVax, Inc. has completed 1 funding round. The latest funding stage is Equity Crowdfunding.
Top alternatives and competitors to TechnoVax, Inc. include KAICO Ltd., OXFORD VACMEDIX UK LIMITED, CaroGen Corporation, Arcturus Therapeutics, Vaxcyte. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TechnoVax, Inc. and KAICO Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors TechnoVax, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy